Lymphoblastic Leukemia, Acute, with Lymphomatous Features (LALL)

Alias:
Acute Lymphoblastic Leukemia with Lymphomatous Features
Leukemia, Acute Lymphoblastic
Lymphomatous All
Lall
Favorite
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Lymphoblastic Leukemia, Acute, with Lymphomatous Features, also known as acute lymphoblastic leukemia with lymphomatous features, is related to leukemia, acute lymphoblastic and leukemia, acute myeloid. An important gene associated with Lymphoblastic Leukemia, Acute, with Lymphomatous Features is CRLF2 (Cytokine Receptor Like Factor 2), and among its related pathways/superpathways are ERK Signaling and TGF-Beta Pathway. The drugs Ifosfamide and Daunorubicin have been mentioned in the context of this disorder. Affiliated tissues include myeloid and spleen, and related phenotypes are lymphoma and acute lymphoblastic leukemia

Basic Information

Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
AR
Unknown
--
8
135
23

Medical Symptom

#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
No data available

Gene & Mutation

#
Gene
Function
Score
Mutations
No data available

Related Drugs

Name
CAS Number
Status
Phase
No data available

Disease Model

Category
Name
MGI
Related Gene
Strain of Origin
Publications
No data available

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Comparison
Al agent
Tutorials
Back to top